Open AccessMetabolically healthy obese women have longer telomere length than obese women with metabolic syndrome
Author(s) -
Andrea Elena Iglesias Molli,
Julieta Panero,
Patricia Carolina Dos Santos,
Claudio González,
Jorge Vilariño,
Marta Sereday,
Gloria Edith Cerrone,
Irma Slavutsky,
Gustavo Frechtel
Publication year - 2017
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0174945
Subject(s) - metabolic syndrome , obesity , medicine , telomere , endocrinology , physiology , biology , genetics , dna
Obesity is the principal component in the Metabolic Syndrome (MetS) that determines the progression of metabolic complications. Metabolically healthy obese (MHO) individuals seem to be protected against those complications. Telomere length (TL) as a novel marker of cellular aging had a complex relationship to the MetS. The principal aim of this study was to investigate the TL in MHO, and to study the association between TL and the worsening of the metabolic condition. Material and methods We have determined the absolute TL (aTL) in 400 women (mean age of 46.76 ± 15.47 years; range: 18–86 years), grouped according to the metabolic condition in three groups: metabolically healthy non-obese women (MHNO), MHO and obese women with MetS (MSO); and grouped according to the number of components of MetS. Results We found that MHO displays significantly higher aTL than MSO (p = 0.033; r = -4.63; 95% CI r = -8.89 / -0.37), but did not differ from MHNO. A decrease in aTL with the progressive increase in the number of MetS components was also observed (p < 0.001; r = -2.06; 95% CI r = -3.13 / -0.99). In this way, our results indicate that aTL is influenced by the presence of MetS, but it is not affected by the presence of obesity. Discussion We found that shorter aTL is not associated with MHO, but is related to MetS and with the increased number of metabolic abnormalities.